References Tesamorelin LiverTox: Clinical and Research Information on Drug-Induced Liver Injury National Institutes of Health, NIDDK (2018) Tesamorelin (Subcutaneous route) Drug Information Mayo Clinic / IBM Merative (2025) Effects of tesamorelin (TH9507), a growth hormonereleasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two phase 3 trials J
Environ Sci Pollut Res 26(13):1350213509 Agerbirk N, Olsen CE (2012) Glucosinolate structures in evolution
For comprehensive guidance, review our reconstituted peptide storage guide
Patients who are pregnant or breastfeeding, patients with active malignancy, patients with certain vascular conditions where angiogenesis is a concern, and patients on specific anticoagulants may not be candidates
Primary site: With the knee relaxed and extended, pinch the skin just below the patella